(Q48352927)

10 February 2018

title

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. (English)

1 reference

10 February 2018

1 reference

Riederer P

1

1 reference

10 February 2018

Youdim MB

series ordinal

2

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 May 1986

1 reference

10 February 2018

Journal of Neurochemistry

published in

1 reference

10 February 2018

volume

46

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

1359-1365

1 reference

10 February 2018

Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the ?cheese effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Dopamine is a monoamine oxidase B substrate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

A rapid microfluorimetric determination of monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Deprenyl in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Rapid screening assay for revertants derived from MSV-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

Human brain monoamine oxidase: multiple forms and selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1986.TB01747.X

10.1111/J.1471-4159.1986.TB01747.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018